title: Knock-down of sorcin induces up-regulation of MDR1 in HeLa cells.
abstract: In our previous study, the MDR1/Pglycoprotein-overexpressing multidrug resistant subline, Hvr100-6, was established from the human cervical carcinoma cell line HeLa-Ohio (HeLa) by stepwise exposure to an anti-microtubule agent, vinblastine sulfate, a typical substrate of MDR1. Their gene and protein expression profiles were analyzed herein, and 148 genes were identified to be differentially expressed by cDNA microarray analysis. The up-regulation of sorcin, a soluble resistance-related calcium-binding protein of 22 kDa, was confirmed in Hvr100-6 cells by the proteome analysis. To clarify the relationship between MDR1 and sorcin, HeLa cells were treated with small interfering RNAs (siRNAs) targeted for theirs mRNAs. The siRNA for MDR1 mRNA resulted in its decrease by 86% and 61% on the days 1 and 2 after the treatment, whereas the expression level of sorcin mRNA was not changed. On the other hand, the siRNA for sorcin mRNA suppressed its expression by 80-90% on days 1-3 after the treatment. Interestingly; suppression of sorcin induced a more than 3-fold increase in the expression level for MDR1 mRNA. An efflux function of MDR1 evaluated with using rhodamine 123 as a probe showed a tendency to be increased in HeLa cells treated with siRNA for sorcin, compared with that in the cells treated with scramble siRNA. The activity and the expression of caspase-3 in the sorcin knock-down HeLa cells were relatively higher than those in the cells treated with scramble siRNA. Thus, we demonstrated that sorcin might be a partial suppressor of MDR1 expression. Furthermore, the present study suggested that sorcin repressed apoptosis via dysfunction of caspase-3.
authors.affiliation: Department of Hospital Pharmacy, School of Medicine, Kobe University, Japan.
authors.forename: Megumi
authors.initials: M
authors.lastname: Kawakami
authors.forename: Tsutomu
authors.initials: T
authors.lastname: Nakamura
authors.forename: Noboru
authors.initials: N
authors.lastname: Okamura
authors.forename: Chiho
authors.initials: C
authors.lastname: Komoto
authors.forename: Svetlana
authors.initials: S
authors.lastname: Markova
authors.forename: Hironao
authors.initials: H
authors.lastname: Kobayashi
authors.forename: Naofumi
authors.initials: N
authors.lastname: Hashimoto
authors.forename: Katsuhiko
authors.initials: K
authors.lastname: Okumura
authors.forename: Toshiyuki
authors.initials: T
authors.lastname: Sakaeda
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000378:metabolism*; D017209:Apoptosis; D002135:Calcium-Binding Proteins / Q000235:genetics*; D053148:Caspase 3 / Q000378:metabolism; D018076:DNA, Complementary / Q000235:genetics; D004591:Electrophoresis, Polyacrylamide Gel; D005434:Flow Cytometry; D005456:Fluorescent Dyes; D006367:HeLa Cells; D006801:Humans; D013058:Mass Spectrometry; D020411:Oligonucleotide Array Sequence Analysis; D010449:Peptide Mapping; D011506:Proteins / Q000032:analysis; D034622:RNA Interference; D012333:RNA, Messenger / Q000378:metabolism; D034741:RNA, Small Interfering / Q000494:pharmacology; D020112:Rhodamine 123; D015854:Up-Regulation
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D002135:Calcium-Binding Proteins; D018076:DNA, Complementary; D005456:Fluorescent Dyes; D011506:Proteins; D012333:RNA, Messenger; D034741:RNA, Small Interfering; C503113:SRI protein, human; D020112:Rhodamine 123; D053148:Caspase 3